AAA MEDICAL CENTER · TMS
Explore Transcranial Magnetic Stimulation (TMS) with personalized attention, clear information, and a professional evaluation.
A non-invasive approach that uses magnetic pulses to stimulate targeted areas of the brain involved in mood regulation.
You remain awake during treatment.
Your history, medications, and any implants are reviewed before treatment.
Your clinician determines whether TMS is appropriate and explains the next steps.
Typical schedule described in our TMS flyer. The device, protocol, and your clinician’s plan may change session length and frequency.
TMS may be considered for adults with depression who have not improved sufficiently with medication or who have difficulty tolerating it. A qualified clinician determines suitability.
Headache or discomfort at the stimulation site can occur. Seizures are a rare serious risk. Your clinician will explain benefits, risks, and device-specific indications.
Drag to rotate in any direction. Use arrow keys to rotate, + / − to zoom, and Home to reset. On touch screens, drag or pinch.
Illustrative 3D approximation based on the supplied reference. Unseen surfaces are inferred.
WEIGHT MANAGEMENT
Explore weight-management options with an individual evaluation and a treatment plan tailored to your needs. Injections are paid services; pricing depends on the prescribed option and plan.
Semaglutide activates GLP-1 receptors involved in appetite regulation. Approved weight-management medicines containing it are used with nutrition and physical activity for eligible patients. Prescription and monitoring are required; nausea, vomiting, or diarrhea may occur. The specific formulation matters.
Tirzepatide acts on GIP and GLP-1 receptors involved in appetite and glucose regulation. Approved weight-management medicines containing it accompany nutrition and physical activity for eligible patients. It requires a prescription and monitoring; nausea, diarrhea, or vomiting may occur. The specific formulation matters.
Retatrutide is an investigational medicine targeting GIP, GLP-1, and glucagon receptors. It is not FDA-approved and cannot legally be compounded under federal law. This description is educational; it is not an offer of routine treatment.
For applicable prescribed treatments, patients receive prepared syringes rather than bottles. Bottle images are illustrative branding concepts; actual dispensing labels and packaging may differ.
Descriptions explain the ingredients generally; they do not mean these illustrated AAA formulations are FDA-approved. Compounded medicines are not FDA-approved. Exact product, prescription, and suitability require clinical confirmation.
Glow, Klow, and MOTS C are listed separately from the weight-management options. Product names alone do not establish ingredients, approval, suitability, or benefits; these details require clinical confirmation.
Glow is a branded formulation name, not a standardized ingredient list. Its exact contents, intended purpose, evidence, and suitability depend on the specific formulation. Those details must be confirmed by the treating professional before a treatment decision.
Klow is a branded formulation name that does not identify a standardized medicine. Ingredients and intended use can vary between formulations. The treating professional must confirm the exact composition, evidence, risks, and suitability before it is considered.
MOTS C refers to MOTS-c, a mitochondrial-derived peptide being studied for metabolic effects. It is not a component of an FDA-approved drug. Research interest does not establish clinical benefits or safety; it is not presented as proven weight-loss treatment.
Illustrative branded bottle concepts. No dosage or concentration is depicted.
No. TMS does not require surgery or anesthesia, and you remain awake.
No. Suitability depends on your health history, medications, the treatment, and a professional evaluation.
Services are paid. The prescribed option and treatment plan determine the price, which should be explained before you start.
For applicable standard treatments, patients receive prepared syringes. The branded bottle images are illustrative and are not dispensing labels.
Our flyer describes 20–40 minutes. Your device and prescribed protocol determine the actual length.
The flyer describes five sessions per week for four to six weeks. Your clinician confirms your schedule.
Bring your medication list and relevant health history. Mention implants, seizures, and previous treatments to the clinician.
Scalp discomfort or headache can occur; seizures are rare. Tell the team about symptoms during treatment.
Do not stop or change prescribed medication on your own. Follow your treating clinician’s instructions.
No. Response and timing vary. Your clinician reviews progress and explains realistic expectations.
Use the phone numbers or email listed at the bottom of this page. The team will confirm availability.
Coverage depends on your insurer, plan, treatment, and authorization requirements. Confirm coverage and personal costs before starting.
AAA MEDICAL CENTER · MIAMI
Appointments, treatment questions, and pricing inquiries.
Confirm your appointment, entrance, and parking before arriving.
Drag the map to explore, use the + and − controls to zoom, and switch between satellite and street views. The initial view shows the surrounding neighborhood at approximately a few miles across; coverage varies with screen size.
